We are live on
!
Find out more
Biogen
BIIB
BIIB
656 hedge funds and large institutions have $52.6B invested in Biogen in 2013 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 227 increasing their positions, 253 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
35% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 54
11% more capital invested
Capital invested by funds: $47.5B → $52.6B (+$5.11B)
2% more funds holding
Funds holding: 646 → 656 (+10)
10% less call options, than puts
Call options by funds: $619M | Put options by funds: $689M
10% less repeat investments, than reductions
Existing positions increased: 227 | Existing positions reduced: 253
17% less funds holding in top 10
Funds holding in top 10: 29 → 24 (-5)
Holders
656
Holders Change
+10
Holders Change %
+1.55%
% of All Funds
21.27%
Holding in Top 10
24
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-17.24%
% of All Funds
0.78%
New
73
Increased
227
Reduced
253
Closed
54
Calls
$619M
Puts
$689M
Net Calls
-$69.9M
Net Calls Change
+$9.03M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$473M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$179M |
| 3 |
O
OppenheimerFunds
New York
|
+$119M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$108M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$104M |
